Visit http://www.Agendia.com to learn more about MammaPrint, the only FDA approved breast cancer recurrence test. Explanation and description of the MammaPrint breast cancer recurrence test which determines whether a breast cancer patient is at "low risk" or "high risk" of metastasis, or breast cancer recurrence. The results from MammaPrint help personalize and determine the best breast cancer therapy for each individual patient.
Link to this comment:
All Comments (0)